Dashboard
Manage Tickers

JAZZ


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

breaking-down-jazz-pharmaceuticals-15-analysts-share-their-views
Breaking Down Jazz Pharmaceuticals: 15 Ana...
04/10/2024 14:01:22

cantor-fitzgerald-reiterates-overweight-on-jazz-pharmaceuticals-maintains-180-price-target
Cantor Fitzgerald Reiterates Overweight on...
04/10/2024 13:37:31

Cantor Fitzgerald analyst Charles Duncan reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and maintains $180 ...

correction-jazz-pharmaceuticals-completes-zanidatamab-biologics-license-application-for-previously-treated-her2-positive-metastatic-biliary-tract-cancer
CORRECTION: Jazz Pharmaceuticals Completes...
04/02/2024 12:00:28

how-to-make-your-cannabis-business-more-attractive-for-investors-in-2024-advice-on-financial-health--innovation
How To Make Your Cannabis Business More At...
03/25/2024 13:39:44

cantor-fitzgerald-reiterates-overweight-on-jazz-pharmaceuticals-maintains-180-price-target
Cantor Fitzgerald Reiterates Overweight on...
03/22/2024 17:49:30

Cantor Fitzgerald analyst Charles Duncan reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and maintains $180 ...

truist-securities-reiterates-buy-on-jazz-pharmaceuticals-maintains-200-price-target
Truist Securities Reiterates Buy on Jazz P...
03/20/2024 15:50:21

Truist Securities analyst Joon Lee reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $200 price target.

the-analyst-landscape-12-takes-on-jazz-pharmaceuticals
The Analyst Landscape: 12 Takes On Jazz Ph...
03/20/2024 14:00:45

piper-sandler-reiterates-overweight-on-jazz-pharmaceuticals-raises-price-target-to-188
Piper Sandler Reiterates Overweight on Jaz...
03/20/2024 12:31:21

Piper Sandler analyst David Amsellem reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price ta...

piper-sandler-maintains-overweight-on-jazz-pharmaceuticals-raises-price-target-to-188
Piper Sandler Maintains Overweight on Jazz...
03/20/2024 11:58:25

Piper Sandler analyst David Amsellem maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price tar...

needham-reiterates-buy-on-jazz-pharmaceuticals-maintains-220-price-target
Needham Reiterates Buy on Jazz Pharmaceuti...
03/20/2024 10:39:43

Needham analyst Ami Fadia reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $220 price target.

stifel-maintains-buy-on-jazz-pharmaceuticals-raises-price-target-to-230
Stifel Maintains Buy on Jazz Pharmaceutica...
03/15/2024 13:37:47

Stifel analyst Annabel Samimy maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and raises the price target from $225 ...

hc-wainwright--co-maintains-buy-rating-for-jazz-pharmaceuticals-heres-what-you-need-to-know
HC Wainwright & Co. Maintains Buy Rating f...
03/14/2024 17:00:21

hc-wainwright--co-maintains-buy-on-jazz-pharmaceuticals-lowers-price-target-to-200
HC Wainwright & Co. Maintains Buy on Jazz ...
03/14/2024 11:28:57

HC Wainwright & Co. analyst Oren Livnat maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and lowers the price tar...

Core News & Articles
CORRECTION: Jury Ruled In Favor Of Avadel ...
03/04/2024 20:52:24

Core News & Articles
Avadel Pharmaceuticals Issues Statement On...
03/04/2024 20:39:50

Avadel Pharmaceuticals plc (NASDAQ:AVDL), today issued a statement in response to a jury ruling from the United States District...

cantor-fitzgerald-reiterates-overweight-on-jazz-pharmaceuticals-maintains-180-price-target
Cantor Fitzgerald Reiterates Overweight on...
02/29/2024 18:13:41

Cantor Fitzgerald analyst Charles Duncan reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and maintains $180 ...

rbc-capital-reiterates-outperform-on-jazz-pharmaceuticals-maintains-195-price-target
RBC Capital Reiterates Outperform on Jazz ...
02/29/2024 17:02:22

RBC Capital analyst Gregory Renza reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Outperform and maintains $195 price t...

jp-morgan-maintains-overweight-on-jazz-pharmaceuticals-lowers-price-target-to-170
JP Morgan Maintains Overweight on Jazz Pha...
02/29/2024 16:37:51

JP Morgan analyst Jessica Fye maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and lowers the price target fro...

demystifying-jazz-pharmaceuticals-insights-from-4-analyst-reviews
Demystifying Jazz Pharmaceuticals: Insight...
02/29/2024 13:00:46

needham-maintains-buy-on-jazz-pharmaceuticals-lowers-price-target-to-220
Needham Maintains Buy on Jazz Pharmaceutic...
02/29/2024 12:41:08

Needham analyst Ami Fadia maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and lowers the price target from $225 to $...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION